$HUTCHMED(00013)$ has been consistently profitable since two years ago, truly embodying the principle of "steady progress over the long term."
The purpose of any company is to create value for its shareholders, and HUTCHMED has gained market trust through its stable profitability and long-term development plans. Over its 19 years since listing, the management has adhered to prudent business practices, with strong free cash flow and resilience to risks.
As an innovative pharmaceutical company that fits the value investment model, HUTCHMED holds great potential for the future. I have full confidence in this stock, will continue to hold firmly, and look forward to the future profitability!
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
